Dr. Andre Goy (@AndreGoyMD) header
Dr. Andre Goy (@AndreGoyMD) profile picture

Physician in Chief Hackensack Meridian Health Oncology Care Transformation Service Chairman & Chief Physician Officer - John Theurer Cancer Center

Hackensack, NJ
Joined September 2009
CURA Foundation 5th Annual Conference. Connecting around Mind Body and Soul to help advance health and cure! #UNITEDTOPREVENT #UNITEDTOCURE Thanks to Robin Smith vision and talent!
1
11
Join me on April 8 during @gotoPER 's Mentors in Medicine Series on Applied Precision Medicine. Tune in to discuss the utilization of immunotherapy in frontline #NSCLC treatment. @HMHNewJersey @HackensackUMC @JTCancerCenter #immunotherapy Register now: ow.ly/IbBI50Eg0vN
8
Join us tonight for a Day 2 of the CME Accredited ASH Update. To register please go to: ow.ly/HDO950E0DPb
1
3
Join Us Tomorrow for Day 2 of the CME Accredited ASH Update. To register please go to ow.ly/uFM750DZaPm
1
3
Tune in NOW to cover the current standards for R-CHOP therapy for lymphoma. Join us for our Mentors in Medicine Series on Applied Precision Medicine webcast, “Focus on R-CHOP in Lymphoma”. Register here: ow.ly/HyyN50DWzZs
1
In 1 hour, you can join the Mentors in Medicine Series webcast to hear a panel of renowned experts discuss the management of adverse events associated with R-CHOP therapy. Join at: ow.ly/Y6HB50DWAbe
1
Our Mentors in Medicine webcast is live NOW. Tune in to gain expert insights on the current standards for triple-negative breast cancer. Join us now at: gotoPER.com/go/MiM2
1
Join Physicians Education Resource®, LLC (PER®) for the 2nd Mentors in Medicine program "Focus on Triple-Negative Breast Cancer" webcast tonight. Tune in at 7:30 PM EST to learn how to incorporate biomarker testing into diagnosis and therapy selection. gotoPER.com/go/MiM2
1
2
Launching our first MENTORS IN MEDICINE w / JOHN THEURER CANCER DEEP DIVING ON PICKING BEST OPTION FOR EVERY PATIENT - AMAZING INSIGHTS FROM Drs ANDERSON LONIAL ALSINA AND BIRAN. PRECISE MEDICINE IN MYELOMA. Thank you for all you DO!
1
3
#DYK age-related changes in endothelial cells play a role in the progression of blood cancers? I had a virtual sit-down with my colleague, Dr. Butler, whose team is exploring how aging endothelial cells lead to blood stem cell function disruption: https://nitter.cf/t.co/gRJVHSkXj8
3
3
I recently spoke to my colleague, @JMBStemCell, whose team is working on unraveling the mechanisms by which aging endothelial cells lead to the disturbance of blood stem cell function, and the progression of certain blood #cancers. Learn more: https://nitter.cf/t.co/rnmSR2Evib
1
2
I virtually sat down with Dr. Rena Feinman, who is working with her team to advance the understanding of the #microbiome and its role in cancer. Learn more about how a better understanding of the microbiome can reshape our approach to cancer treatment: https://nitter.cf/t.co/08bWKZlMC5
4
9
#DYK there is growing evidence that the #microbiome plays an important role in many aspects of human cancers – including progression and treatment response? I had a virtual sit-down with my colleague, Dr. Rena Feinman, to learn more: https://nitter.cf/t.co/08bWKZlMC5
4
Join me on tomorrow, September 26 as I lead @gotoPER's "2nd Annual Precision Medicine Symposium: An Illustrated Tumor Board" virtual, interactive conference to hear the latest clinical insights in major solid and liquid tumors. Register at: https://nitter.cf/t.co/e1zVr7rbmG
5
I had the opportunity to virtually sit-down with Dr. Benjamin Tycko, my colleague and co-author on a new study that can help unlock the potential of #epigenetics. Learn more about how these exciting findings can impact cancer treatment: https://nitter.cf/t.co/NrUV50zzId
Our team at @JTCancerCenter recently participated in a study delving into the fairly new field of #epigenetics. The exciting findings revealed signposts in DNA that may pinpoint risks for cancer and other diseases. Learn more: https://nitter.cf/t.co/NrUV50zzId
1
3
Great News: The FDA has approved the CAR T-cell therapy brexucabtagene autoleucel (Tecartus; formerly KTE-X19) as a treatment for adult patients with relapsed/refractory mantle cell #lymphoma.
2
2
16
Members of our @JTCancerCenter team recently participated in the #ASCO20 virtual conference, contributing to 24 innovative data presentations across a wide variety of focus areas in #cancer research. Learn more in my latest article: https://nitter.cf/t.co/HMD5A5ERZL
2
2
The MAKING of JOHN THEURER CANCER CENTER was made possible thanks to HELENA THEURER BELIEVING in us AND THE TALENT / DEDICATION of so MANY 1st and foremost all my COLLEAGUES EXPERTS without whom nothing would have happened.
3
3